O. Mäkelä

4.1k total citations
122 papers, 3.1k citations indexed

About

O. Mäkelä is a scholar working on Radiology, Nuclear Medicine and Imaging, Molecular Biology and Immunology. According to data from OpenAlex, O. Mäkelä has authored 122 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 63 papers in Radiology, Nuclear Medicine and Imaging, 51 papers in Molecular Biology and 48 papers in Immunology. Recurrent topics in O. Mäkelä's work include Monoclonal and Polyclonal Antibodies Research (60 papers), T-cell and B-cell Immunology (21 papers) and Glycosylation and Glycoproteins Research (18 papers). O. Mäkelä is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (60 papers), T-cell and B-cell Immunology (21 papers) and Glycosylation and Glycoproteins Research (18 papers). O. Mäkelä collaborates with scholars based in Finland, United States and Sweden. O. Mäkelä's co-authors include Ilkka Seppälä, Klaus Karjalainen, Heikki Sarvas, Pentti Kuusela, G. J. V. Nossal, Petri S. Mattila, Peter Roberts‎, Hannu Jalanko, Matti Kaartinen and K Karjalainen and has published in prestigious journals such as Nature, The Journal of Experimental Medicine and The Journal of Immunology.

In The Last Decade

O. Mäkelä

120 papers receiving 2.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
O. Mäkelä Finland 34 1.4k 1.2k 1.0k 569 328 122 3.1k
David C. Parker United States 40 3.9k 2.8× 1.1k 0.9× 1.1k 1.0× 450 0.8× 500 1.5× 96 5.3k
S M Colón United States 29 3.8k 2.7× 1.8k 1.4× 1.8k 1.8× 460 0.8× 362 1.1× 40 5.4k
Doris Scheidegger Switzerland 13 3.1k 2.3× 885 0.7× 1.3k 1.3× 363 0.6× 590 1.8× 16 4.6k
Helen Tighe United States 25 3.0k 2.2× 557 0.5× 1.2k 1.2× 636 1.1× 371 1.1× 43 4.8k
Hans Reiser United States 37 2.7k 1.9× 515 0.4× 719 0.7× 803 1.4× 513 1.6× 62 4.1k
Robert W. Karr United States 32 3.0k 2.2× 912 0.8× 874 0.9× 392 0.7× 299 0.9× 84 4.3k
David E. Isenman Canada 37 2.4k 1.7× 948 0.8× 1.2k 1.2× 301 0.5× 130 0.4× 76 3.7k
Margaret Goodall United Kingdom 31 1.7k 1.2× 1.2k 0.9× 1.3k 1.3× 334 0.6× 216 0.7× 76 3.6k
B. Michael Longenecker Canada 44 2.7k 2.0× 1.8k 1.5× 3.0k 3.0× 475 0.8× 1.0k 3.2× 121 5.1k
Milan Tomana United States 38 1.8k 1.3× 1.3k 1.0× 2.1k 2.1× 307 0.5× 173 0.5× 93 5.4k

Countries citing papers authored by O. Mäkelä

Since Specialization
Citations

This map shows the geographic impact of O. Mäkelä's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by O. Mäkelä with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites O. Mäkelä more than expected).

Fields of papers citing papers by O. Mäkelä

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by O. Mäkelä. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by O. Mäkelä. The network helps show where O. Mäkelä may publish in the future.

Co-authorship network of co-authors of O. Mäkelä

This figure shows the co-authorship network connecting the top 25 collaborators of O. Mäkelä. A scholar is included among the top collaborators of O. Mäkelä based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with O. Mäkelä. O. Mäkelä is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Lord, Peter F., Anders Eriksson, Jens Häggström, et al.. (2003). Increased Pulmonary Transit Times in Asymptomatic Dogs with Mitral Regurgitation. Journal of Veterinary Internal Medicine. 17(6). 824–829. 17 indexed citations
3.
Mäkelä, O., et al.. (2003). Radiation Synovectomy With Holmium‐166 Ferric Hydroxide Macroaggregate in Equine Metacarpophalangeal and Metatarsophalangeal Joints. Veterinary Surgery. 32(4). 402–409. 9 indexed citations
4.
Mäkelä, O., et al.. (2002). Analysis of lapine cartilage matrix after radiosynovectomy with holmium-166 ferric hydroxide macroaggregate. Annals of the Rheumatic Diseases. 62(1). 43–49. 29 indexed citations
5.
Mäkelä, O., et al.. (2002). Experimental radiation synovectomy in rabbit knee with holmium-166 ferric hydroxide macroaggregate. Nuclear Medicine and Biology. 29(5). 593–598. 10 indexed citations
6.
Mattila, Petri S., et al.. (1995). Extensive allelic sequence variation in the J region of the human immunoglobulin heavy chain gene locus. European Journal of Immunology. 25(9). 2578–2582. 39 indexed citations
7.
Ibrahim, Saleh, Ilkka Seppälä, Heikki Sarvas, & O. Mäkelä. (1993). Proportion of protein A bindable molecules in human IgM and IgA antibodies to seven antigens. Microbial Pathogenesis. 15(3). 159–168. 3 indexed citations
8.
Ibrahim, Saleh, Ilkka Seppälä, & O. Mäkelä. (1993). V-region-mediated binding of human Ig by protein A.. The Journal of Immunology. 151(7). 3597–3603. 11 indexed citations
9.
Seppälä, Ilkka, Heikki Sarvas, O. Mäkelä, et al.. (1988). Human Antibody Responses to Two Conjugate Vaccines of Haemophilus influenzae Type B Saccharides and Diphtheria Toxin. Scandinavian Journal of Immunology. 28(4). 471–479. 33 indexed citations
10.
Kaartinen, Matti & O. Mäkelä. (1985). Reading of D genes in variable frames as a source of antibody diversity. Immunology Today. 6(11). 324–327. 51 indexed citations
11.
Fernández, Carmen, O. Mäkelä, & Göran Möller. (1980). Genetics of the anti-dextran B512 and the autoanti-idiotypic response: Codominant expression in F1 hybrids and dichotomy of response and allotype-linked idiotype. Immunogenetics. 10(5). 573–582. 2 indexed citations
12.
Hurme, Mikko, K Karjalainen, & O. Mäkelä. (1980). Failure to Demonstrate Public Idiotypes on Cytolytic Cells with Specificity for NP‐coupled Syngeneic Cells. Scandinavian Journal of Immunology. 11(3). 241–246. 17 indexed citations
13.
Mäkelä, O., Mikko Julin, & Martin Becker. (1976). Inheritance of antibody specificity. III. A new VH gene controls fine specificity of anti-p-azobenzenearsonate coupled to the carbon atom 5 of hydroxyphenylacetic acid in the mouse.. The Journal of Experimental Medicine. 143(2). 316–328. 34 indexed citations
15.
Penttinen, K, G. Myllylä, O. Mäkelä, & Antti Vaheri. (1969). SOLUBLE ANTIGEN‐ANTIBODY COMPLEXES AND PLATELET AGGREGATION. Acta Pathologica Microbiologica Scandinavica. 77(2). 309–317. 41 indexed citations
16.
Seppälä, Markku, Erkki Ruoslahti, & O. Mäkelä. (1967). Inheritance and Genetic Linkage of Gc and Tf Groups. Human Heredity. 17(1). 47–54. 4 indexed citations
17.
Mäkelä, O., et al.. (1967). In vitro transformation of the Lewis blood groups of erythrocytes.. PubMed. 45(2). 159–64. 3 indexed citations
18.
Mäkelä, O. & G. J. V. Nossal. (1962). AUTORADIOGRAPHIC STUDIES ON THE IMMUNE RESPONSE. The Journal of Experimental Medicine. 115(1). 231–244. 114 indexed citations
19.
Mäkelä, O., et al.. (1959). ON THE INHERITANCE OF THE HAPTOGLOBIN SERUM GROUPS. Human Heredity. 9(2). 149–166. 18 indexed citations
20.
Mäkelä, O., Pirjo Mäkelä, & R. Lehtovaara. (1959). Sugar specificity of plant hemagglutinins (lectins).. PubMed. 37. 328–35. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026